Merck to Acquire Acceleron Pharma Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Merck (MRK) to Acquire Acceleron Pharma (XLRN) for $11.5 Billion, Deal Brings in Potential Blockbuster in PAH Says Analyst
September 30, 2021 7:56 AM EDTMerck (NYSE: MRK) announced today that it has agreed to acquire Acceleron Pharma (Nasdaq: XLRN) for $180 per share in cash in the deal valued at $11.5 billion.
Todays announcement has confirmed media reports that XLRN is in advanced talks with MRK over a takeover deal.
Strategic business development is a top... More
